Postoperative aRCH With Cisplatin Versus aRCH With Cisplatin and Pembrolizumab in Locally Advanced Head and Neck Squamous Cell Carcinoma
Clinical trial NCT03480672 · COMPLETED
Trial details
- NCT number
- NCT03480672
- Sponsor
- University of Leipzig
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-08-06
- Primary completion
- 2025-01-30
- Enrollment
- 211
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.